论文部分内容阅读
新药的“基础研究文献目录”向科学家们表示了软性激励,并认可基础生物医学研究的价值。哈佛大学公共卫生学院健康政策教授大卫·海明威(David Hemenway),布莱恩特大学法律研究副教授安德里亚·博焦(Andrea Boggio),哈佛大学公共卫生学院科学政策研究员安德里亚·巴拉贝尼(Andrea Ballabeni)联合撰文,呼吁从政策出发,重视基础科学研究。基础生物医学研究是征服一些在全球范围内迅速传播的传染性疾病的关键,也是研究越来越多的人过早死亡背后的非传染条件的关键。许多学者
The new drug’s “Bibliography of Essential Research Literature” presents scientists with soft incentives and acknowledges the value of basic biomedical research. David Hemenway, Harvard School of Public Health Professor of Health Policy, Andrea Boggio, associate professor of law at Bryant University, and Andrea Barrabe, a science policy researcher at the Harvard School of Public Health Andrea Ballabeni, co-author, called for a policy that places emphasis on basic scientific research. Fundamental biomedical research is the key to overcoming some of the rapidly spreading infectious diseases on a global scale and the key to studying the non-communicable conditions behind the growing number of people who die prematurely. Many scholars